Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · RheumatologyMedium impact
Anti-CCP Testing for Rheumatoid Arthritis
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
Measurement of anti-CCP may be considered medically necessary when used as part of the diagnostic work-up for rheumatoid arthritis, up to two times per calendar year. Measurement of anti-CCP is considered investigational when used to monitor disease activity or treatment response. The covered code is CPT 86200, paired with covered ICD-10 diagnosis codes for rheumatoid arthritis and other unspecified arthropathy, juvenile arthritis, pain in joint, and stiffness of joint.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
01Billing team: For CPT 86200, claims for the diagnostic work-up of rheumatoid arthritis may be medically necessary up to two times per calendar year.
02Anti-CCP measurement used to monitor disease activity or treatment response is considered investigational under this policy.
03Use the covered ICD-10 diagnosis codes in the code reference when billing CPT 86200: M05.00 through M08.99, M12.00 through M12.09 (rheumatoid arthritis and other unspecified arthropathy), M08.9A (juvenile arthritis, unspecified, other specified site), M25.50 through M25.579 (pain in joint), M25.59 (pain in other specified joint), M25.60 through M25.676 (stiffness of joint), and M25.69 (stiffness of other specified joint).
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.